Description
Ligandrol (LGD4033) 10 mg Driada Medical — ligandrol (LGD-4033) from Driada Medical at 10 mg. Non-steroidal SARM with strong AR affinity and tissue-selective agonism. Moderate HPTA suppression; mini-PCT recommended after 8+ week cycles.
Key Benefits
- Strongest SARM for lean-mass accrual
- 5–10 mg/day produces measurable suppression — mandatory PCT
- More water retention than Ostarine at higher doses
- Oral once-daily
- Not a “mild” SARM — treat protocol seriously
- Each unit dosed at 10 mg — see Recommended Dosage below for protocol-specific intake
Recommended Dosage
Research dosing: 5–10 mg/day for 8 weeks. Above 10 mg/day suppression becomes severe and water retention noticeable. Single daily dose.
How It Works
LGD-4033, high-affinity SARM with strong tissue selectivity for muscle and bone. Potent AR activator — stronger mass-building effect than Ostarine at equivalent dose.
Pharmacokinetics
Plasma half-life approximately 24–36 hours. Once-daily dosing fine. Steady-state 7 days.
Potential Side Effects
HPTA suppression meaningful at 10+ mg/day. HDL drops. Mild water retention at higher doses. Mood and aggression changes possible.
Cycle & Stacking Guide
8-week cycles at 5–10 mg/day. PCT mandatory: Nolva 20 mg/day × 4 weeks. Can be stacked with Ostarine (10+10 mg) or RAD-140 for more aggressive recomp — but bloodwork discipline required.
Manufacturer Notes
Driada Medical positions itself at the affordable end of the market while maintaining third-party lab verification. Their vial caps carry a tamper-seal date code.
Storage & Handling
Store in the original blister or bottle at 15–25 °C, away from direct sunlight, heat, and humidity. Oral preparations lose potency faster if exposed to moisture; keep the desiccant (if included) with the tablets. Keep out of reach of children. For research and educational purposes only.
Reviews
There are no reviews yet.